Skip to main content

Lamotrigine

NDC 65862-229 · Aurobindo Pharma Limited

Generic nameLamotrigine
Dosage formTABLET
RouteORAL
Active ingredient(s)LAMOTRIGINE
Strength150 mg/1
Pharmacologic classAnti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE], Dihydrofolate Reductase Inhibitors [MoA], Mood Stabilizer [EPC], Organic Cation Transporter 2 Inhibitors [MoA]
Marketing categoryANDA

Packages

65862-229-01 — 100 TABLET in 1 BOTTLE (65862-229-01)

65862-229-60 — 60 TABLET in 1 BOTTLE (65862-229-60)

65862-229-78 — 10 BLISTER PACK in 1 CARTON (65862-229-78) / 10 TABLET in 1 BLISTER PACK (65862-229-10)

65862-229-99 — 1000 TABLET in 1 BOTTLE (65862-229-99)

Related Codes

Same active ingredient

FDA lists these products with the same active ingredient.

65841-682 — Lamotrigine, 65841-683 — Lamotrigine, 65841-684 — Lamotrigine, 65841-685 — Lamotrigine, 65841-686 — Lamotrigine, 65841-687 — Lamotrigine, 65841-689 — Lamotrigine, 65841-690 — Lamotrigine, 65862-227 — Lamotrigine, 65862-228 — Lamotrigine, 65862-230 — Lamotrigine, 65862-361 — Lamotrigine, 65862-362 — Lamotrigine, 67046-0358 — Lamotrigine, 67046-0359 — Lamotrigine, 67046-0749 — Lamotrigine, 67046-1573 — Lamotrigine, 67877-164 — Lamotrigine, 67877-165 — Lamotrigine, 67877-166 — Lamotrigine, +270 more

From the FDA National Drug Code Directory, retrieved August 24, 2026. Product listings are submitted by labelers; FDA does not verify them.

Read from: FDA National Drug Code Directory, product.txt and package.txt (accessdata.fda.gov/cder/ndctext.zip) — Snapshot retrieved 2026-08-24, loaded 2026-08-24; CMS Medicare Part B Drug Average Sales Price (ASP) Pricing Files (cms.gov/medicare/payment/part-b-drugs/asp-pricing-files) -- the NDC-HCPCS crosswalk and Part B payment limit files — 2026 Q3 (July 2026 release). All data sources · How to read the labels